Signa Vitae 2020
DOI: 10.22514/sv.2020.16.0036
|View full text |Cite
|
Sign up to set email alerts
|

Gastric Outlet Obstruction Due to Cholecysto-Gastric Fistula: Bouveret’s Syndrome

Abstract: Bouveret’s syndrome is defined as gastrointestinal obstruction due to an impacted gallstone secondary to biliary-enteric fistula. This is often observed with nonspecific symptoms such as epigastric pain, nausea, and vomiting. The diagnosis is made by visualization of pneumobilia, gastric outlet obstruction and ectopic gallstone. In this report, we discussed an elderly patient who was admitted to the emergency department with abdominal pain and vomiting without any signs of bowel obstruction in plain x-ray and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
(17 reference statements)
0
1
0
Order By: Relevance
“…Lymph node metastasis or even distant organ metastasis has been found in most GC patients at first diagnosis, which could not be cured through surgery and affected the prognosis and survival rate of patients (Karimi et al 2014 ; Tan 2019 ; Na et al 2021 ). Despite the continuous development of endoscopic technology and the remarkable progress of immunotherapy, the current GC therapeutic effect is restricted, so the death rate of GC in China keeps high (Zong et al 2016 ; Zhang and Yu 2020 ; Sezik et al 2021 ; Sun et al 2021 ). Therefore, distinguishing novel biomolecules and signaling pathways may supply potential therapeutic strategies for GC.…”
Section: Introductionmentioning
confidence: 99%
“…Lymph node metastasis or even distant organ metastasis has been found in most GC patients at first diagnosis, which could not be cured through surgery and affected the prognosis and survival rate of patients (Karimi et al 2014 ; Tan 2019 ; Na et al 2021 ). Despite the continuous development of endoscopic technology and the remarkable progress of immunotherapy, the current GC therapeutic effect is restricted, so the death rate of GC in China keeps high (Zong et al 2016 ; Zhang and Yu 2020 ; Sezik et al 2021 ; Sun et al 2021 ). Therefore, distinguishing novel biomolecules and signaling pathways may supply potential therapeutic strategies for GC.…”
Section: Introductionmentioning
confidence: 99%